Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer

被引：0
|
作者：
Zaisheng Ye
Yi Zeng
Shenghong Wei
Yi Wang
Zhitao Lin
Shu Chen
Zhiwei Wang
Shanshan Chen
Luchuan Chen
机构：
[1] Fujian Cancer Hospital & Fujian Medical University Cancer Hospital,Department of Gastrointestinal Surgical Oncology
[2] Fujian Cancer Hospital & Fujian Medical University Cancer Hospital,Department of Fujian Provincial Key Laboratory of Tumor Biotherapy
来源：
BMC Cancer | / 21卷
关键词：
Unresectable gastric cancer; Conversion therapy; Apatinib; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
    Zhao, Jian
    Lei, Junmei
    Yu, Junyan
    Zhang, Chengyan
    Song, Xuefeng
    Zhang, Ninggang
    Wang, Yusheng
    Zhang, Suxiang
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 500 - 506
  • [22] Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer
    Takahiro Tsushima
    Shuichi Hironaka
    Narikazu Boku
    Nozomu Machida
    Kentaro Yamazaki
    Hirofumi Yasui
    Akira Fukutomi
    Akiko Todaka
    Hiroya Taniguchi
    Yusuke Onozawa
    Keisei Taku
    International Journal of Clinical Oncology, 2013, 18 : 10 - 16
  • [23] Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer
    Tsushima, Takahiro
    Hironaka, Shuichi
    Boku, Narikazu
    Machida, Nozomu
    Yamazaki, Kentaro
    Yasui, Hirofumi
    Fukutomi, Akira
    Todaka, Akiko
    Taniguchi, Hiroya
    Onozawa, Yusuke
    Taku, Keisei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (01) : 10 - 16
  • [24] Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer
    Yang, Honglan
    Sui, Yanmin
    Guo, Xingjun
    Tan, Xiaojing
    Li, Yan
    Wang, Minglin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S1148 - S1151
  • [25] Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
    Jian Zhao
    Junmei Lei
    Junyan Yu
    Chengyan Zhang
    Xuefeng Song
    Ninggang Zhang
    Yusheng Wang
    Suxiang Zhang
    Investigational New Drugs, 2020, 38 : 500 - 506
  • [26] Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer
    Takahiro Tsushima
    Shuichi Hironaka
    Narikazu Boku
    Nozomu Machida
    Kentaro Yamazaki
    Hirofumi Yasui
    Keisei Taku
    Akira Fukutomi
    Yusuke Onozawa
    Gastric Cancer, 2010, 13 : 245 - 250
  • [27] Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer
    Tsushima, Takahiro
    Hironaka, Shuichi
    Boku, Narikazu
    Machida, Nozomu
    Yamazaki, Kentaro
    Yasui, Hirofumi
    Taku, Keisei
    Fukutomi, Akira
    Onozawa, Yusuke
    GASTRIC CANCER, 2010, 13 (04) : 245 - 250
  • [28] Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma
    Zheng, Yanan
    Wang, Zhenqiang
    Yan, Chao
    Yan, Min
    Hou, Zhiguo
    Zheng, Rongrong
    Zhu, Zhenggang
    Li, Chen
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [29] Efficacy and safety of sintilimab combined with apatinib as third-line or above therapy for patients with advanced or metastatic gastric cancer
    Gao, Loulu
    Tang, Lin
    Li, Xiaoqian
    Peng, Jieqiong
    Hu, Zixuan
    Liu, Bo
    ANTI-CANCER DRUGS, 2024, 35 (03) : 277 - 283
  • [30] Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer
    Zhang, Yonglei
    Zhang, Bin
    Yang, Jinpo
    Zhang, Jindai
    Zhang, Wei
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2279 - 2286
12345